Plasmonic-Fluorescent Janus Ag/Ag<sub>2</sub>S Nanoparticles for <i>In Situ</i> H<sub>2</sub>O<sub>2</sub>-Activated NIR-II Fluorescence ImagingXuan Zhang, Hongwei Duan, Wenli Wang et al.|Nano Letters|2021Cited by 109
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S. Bajaj, Mingqin Lu, Ashok Choudhury et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 33
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Junqi Niu, Wen Chen et al.|Clinical Infectious Diseases|2021Cited by 15
Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trialsYanhang Gao, Junqi Niu, Fei Kong et al.|Journal of Hepatology|2020Cited by 0
Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED studyJasmohan S. Bajaj, Anil Anora, F. Susan Wong et al.|Journal of Hepatology|2023Cited by 0